...
首页> 外文期刊>CNS neuroscience & therapeutics. >Inhibition of G Protein‐Coupled Receptor 81 ( GPR 81) Protects Against Ischemic Brain Injury
【24h】

Inhibition of G Protein‐Coupled Receptor 81 ( GPR 81) Protects Against Ischemic Brain Injury

机译:G蛋白偶联受体81(GPR 81)的抑制作用可预防缺血性脑损伤

获取原文

摘要

Summary Aim Lactates accumulate in ischemic brains. G protein‐coupled receptor 81 ( GPR 81) is an endogenous receptor for lactate. We aimed to explore whether lactate is involved in ischemic injury via activating GPR 81. Methods N2A cells were transfected with GFP ‐ GPR 81 plasmids 24 h previously, and then treated with GPR 81 antagonist 3‐hydroxy‐butyrate (3‐ OBA ) alone or cotreated with agonists lactate or 3, 5‐dihydroxybenzoic acid (3, 5‐ DHBA ) during 3 h of oxygen–glucose deprivation ( OGD ). Adult male C57 BL /6J mice and primary cultured cortical neurons were treated with 3‐ OBA at the onset of middle cerebral artery occlusion ( MCAO ) or OGD , respectively. Results The GPR 81 overexpression increased the cell vulnerability to ischemic injury. And GPR 81 antagonism by 3‐ OBA significantly prevented cell death and brain injury after OGD and MCAO , respectively. Furthermore, inhibition of GPR 81 reversed ischemia‐induced apoptosis and extracellular signal‐regulated kinase ( ERK ) signaling may be involved in the neuroprotection. Conclusions G protein‐coupled receptor 81 ( GPR 81) inhibition attenuated ischemic neuronal death. Lactate may aggravate ischemic brain injury by activating GPR 81. GPR 81 antagonism might be a novel therapeutic strategy for the treatment of cerebral ischemia.
机译:摘要目的乳酸在缺血性脑中积累。 G蛋白偶联受体81(GPR 81)是乳酸的内源性受体。我们旨在探讨乳酸是否通过激活GPR 81参与缺血性损伤。方法N2A细胞在24小时前用GFP ‐ GPR 81质粒转染,然后单独或通过GPR 81拮抗剂3-羟基丁酸酯(3-OBA)处理在氧葡萄糖剥夺(OGD)的3小时内与激动剂乳酸或3,5-二羟基苯甲酸(3,5-DHBA)共同治疗。成年雄性C57 BL / 6J小鼠和原代培养的皮质神经元在大脑中动脉闭塞(MCAO)或OGD发作时分别接受3-OBA治疗。结果GPR 81过表达增加了细胞对缺血性损伤的脆弱性。 3-OBA对GPR 81的拮抗作用分别显着预防了OGD和MCAO后的细胞死亡和脑损伤。此外,抑制GPR 81可逆转缺血诱导的细胞凋亡和细胞外信号调节激酶(ERK)信号传导,这可能与神经保护作用有关。结论G蛋白偶联受体81(GPR 81)抑制可减轻缺血性神经元死亡。乳酸可能通过激活GPR 81加剧缺血性脑损伤。GPR81拮抗作用可能是治疗脑缺血的一种新型治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号